These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7559186)

  • 1. Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria.
    Rodriguez-Tudela JL; Martinez-Suárez JV
    J Antimicrob Chemother; 1995 Jun; 35(6):739-49. PubMed ID: 7559186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans.
    Rodríguez-Tudela JL; Berenguer J; Martínez-Suárez JV; Sanchez R
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1998-2003. PubMed ID: 8878570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved medium for fluconazole susceptibility testing of Candida albicans.
    Rodriguez-Tudela JL; Martinez-Suarez JV
    Antimicrob Agents Chemother; 1994 Jan; 38(1):45-8. PubMed ID: 8141578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation.
    Odds FC; Vranckx L; Woestenborghs F
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2051-60. PubMed ID: 8540715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a new colorimetric assay with the NCCLS broth microdilution method (M-27A) for antifungal drug MIC determination.
    Li RK; Elie CM; Clayton GE; Ciblak MA
    J Clin Microbiol; 2000 Jun; 38(6):2334-8. PubMed ID: 10834998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collaborative investigation of broth microdilution and semisolid agar dilution for in vitro susceptibility testing of Candida albicans.
    Shawar R; Paetznick V; Witte Z; Ensign LG; Anaissie E; LaRocco M
    J Clin Microbiol; 1992 Aug; 30(8):1976-81. PubMed ID: 1500502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures.
    Chang HC; Chang JJ; Huang AH; Chang TC
    J Clin Microbiol; 2000 Mar; 38(3):971-6. PubMed ID: 10698982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pH and buffer system on the in-vitro activity of five antifungals against yeasts.
    Gadea I; Cuenca M; Gegúndez MI; Zapardiel J; Valero ML; Soriano F
    J Antimicrob Chemother; 1997 Apr; 39(4):453-9. PubMed ID: 9145817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro sensitivity tests for yeasts: evaluation of a micromethod].
    Rodero LL; Davel GO; Vivot W; Canteros CE; Fernández C
    Rev Argent Microbiol; 1995; 27(2):81-9. PubMed ID: 8552761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.
    Radetsky M; Wheeler RC; Roe MH; Todd JK
    J Clin Microbiol; 1986 Oct; 24(4):600-6. PubMed ID: 3771749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents.
    Favel A; Michel-Nguyen A; Datry A; Challier S; Leclerc F; Chastin C; Fallague K; Regli P
    J Antimicrob Chemother; 2004 Mar; 53(3):526-9. PubMed ID: 14963064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients.
    Rodríguez-Tudela JL; Martínez-Suárez JV; Dronda F; Laguna F; Chaves F; Valencia E
    J Antimicrob Chemother; 1995 Jun; 35(6):793-804. PubMed ID: 7559191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of human serum on antifungal pharmacodynamics with Candida albicans.
    Zhanel GG; Saunders DG; Hoban DJ; Karlowsky JA
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2018-22. PubMed ID: 11408217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose.
    Espinel-Ingroff A; Pfaller M; Erwin ME; Jones RN
    J Clin Microbiol; 1996 Apr; 34(4):848-52. PubMed ID: 8815095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine.
    Pfaller MA; Bale M; Buschelman B; Lancaster M; Espinel-Ingroff A; Rex JH; Rinaldi MG; Cooper CR; McGinnis MR
    J Clin Microbiol; 1995 May; 33(5):1104-7. PubMed ID: 7615713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of media on growth rate and susceptibility testing of Cryptococcus neoformans.
    St-Germain G; Dion C
    Mycoses; 1996; 39(5-6):201-6. PubMed ID: 8909030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
    Vivas JR; Torres-Rodríguez JM
    Rev Esp Quimioter; 2001 Jun; 14(2):191-7. PubMed ID: 11704774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the fluorescein diacetate assay for screening of antifungal agents against Candida albicans: comparison with the NCCLS methods.
    Brouwer N; Kohen J; Jamie J; Vemulpad S
    J Microbiol Methods; 2006 Aug; 66(2):234-41. PubMed ID: 16406566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain.
    Martinez-Suarez JV; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1512-6. PubMed ID: 7492095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G; Manzara S; Dettori G
    Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.